Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Sham Mailankody"'
Autor:
Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura, Sean M. Devlin, Tasmin Farzana, Sridevi Rajeeve, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Alexander M. Lesokhin, Urvi A. Shah, Carlyn R. Tan, Sergio A. Giralt, Saad Z. Usmani, Karthik Nath, Sham Mailankody
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Despite being the mainstay of management for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), there is limited data regarding the impact of tocilizumab (TCZ) and corticosteroids (CCS) on chi
Externí odkaz:
https://doaj.org/article/b0599253316a411c8f7c1eb08d801e0c
Autor:
Karthik Nath, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Bruno Almeida Costa, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Neha Korde, Urvi A. Shah, Carlyn Rose Tan, Malin Hultcrantz, Sergio A. Giralt, Saad Z. Usmani, Zainab Shahid, Sham Mailankody, Alexander M. Lesokhin
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this retrospective, single-center analysis we evaluated infectious complications after BCMA-targ
Externí odkaz:
https://doaj.org/article/6b93aedeb2774601928a329b4bbfda19
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Although multiple myeloma is an incurable disease, the past decade has witnessed significant improvement in patient outcomes. This was brought about by the development of T-cell redirection therapies such as chimeric antigen receptor (CAR) T-cells, w
Externí odkaz:
https://doaj.org/article/cb01826a48704e59aa792602432d229d
Autor:
Wai Lun Will Pak, Natalie A. Brumwell, Charlene C. Kabel, Victoria Gutgarts, Insara Jaffer Sathick, Sham Mailankody, Alexander M. Lesokhin, Heather J. Landau, Aisha Shaikh
Publikováno v:
Kidney Medicine, Vol 6, Iss 8, Pp 100856- (2024)
Chimeric antigen receptor (CAR) T-cell therapy against B-cell maturation antigen is a new treatment modality for relapsed or refractory multiple myeloma (MM). Patients with kidney failure and MM were excluded from the pivotal CAR T-cell therapy clini
Externí odkaz:
https://doaj.org/article/b441d1d4e60349e08b3cb758bb808407
Autor:
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, Dhwani Patel, Oscar B. Lahoud, Heather J. Landau, David J. Chung, Gunjan L. Shah, Michael Scordo, Sergio A. Giralt, Alexander Lesokhin, Saad Z. Usmani, Ola Landgren, Neha Korde
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Lenalidomide and dexamethasone with bortezomib (VRd) or carfilzomib (KRd) are commonly used induction regimens in the U.S. This single-center, retrospective study evaluated outcomes and safety of VRd and KRd. Primary endpoint was progression
Externí odkaz:
https://doaj.org/article/cffbd554fa414cab9e44d309fb48abab
Autor:
Allison Lipitz‐Snyderman, Susan Chimonas, Sham Mailankody, Michelle Kim, Nicholas Silva, Anuja Kriplani, Leonard B. Saltz, Smita Sihag, Carlyn Rose Tan, Maria Widmar, Marjorie Zauderer, Saul Weingart, Wendy Perchick, Benjamin R. Roman
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8063-8072 (2023)
Abstract Background Data on the clinical value of second opinions in oncology are limited. We examined diagnostic and treatment changes resulting from second opinions and the expected impact on morbidity and prognosis. Methods This retrospective coho
Externí odkaz:
https://doaj.org/article/10ae402ba98547979699cff1e9bf523b
Autor:
Ross Firestone, Tala Shekarkhand, Dhwani Patel, Malin Hultcrantz, Alexander Lesokhin, Sham Mailankody, Hani Hassoun, Carlyn Tan, Urvi Shah, Neha Korde, Kylee Maclachlan, Heather Landau, David Chung, Gunjan Shah, Sergio Giralt, Oscar Lahoud, Saad Usmani
Publikováno v:
HemaSphere, Vol 7, p e81198bb (2023)
Externí odkaz:
https://doaj.org/article/80f157d8d0044f4b8adb43f7d6c5e9a3
Autor:
Urvi A. Shah, Karissa Whiting, Sean Devlin, Rachel Ershler, Bindu Kanapuru, David J. Lee, Sabrin Tahri, Thomas Gwise, Even H. Rustad, Sham Mailankody, Alexander M. Lesokhin, Dickran Kazandjian, Francesco Maura, Daniel Auclair, Brenda M. Birmann, Saad Z. Usmani, Nicole Gormley, Catherine R. Marinac, Ola Landgren
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
Externí odkaz:
https://doaj.org/article/b9615b6311034833a6271e024f2e624b
Autor:
Neha Korde, Elizabet Tavitian, Donna Mastey, Joseph Lengfellner, Gil Hevroni, Andrew Zarski, Meghan Salcedo, Sham Mailankody, Hani Hassoun, Eric L. Smith, Malin Hultcrantz, Urvi Shah, Carlyn Tan, Benjamin Diamond, Gunjan Shah, Michael Scordo, Oscar Lahoud, David J. Chung, Heather Landau, Sergio Giralt, Andriy Derkach, Thomas M. Atkinson, Paul Sabbatini, Francesca König, Saad Z. Usmani, Ola Landgren, Alexander M. Lesokhin
Publikováno v:
EClinicalMedicine, Vol 57, Iss , Pp 101854- (2023)
Summary: Background: Due to the nature of their disease, patients with multiple myeloma (MM) often have bone disease-related pain that limits physical activity and diminishes health-related quality of life (HRQOL). Digital health technology with wear
Externí odkaz:
https://doaj.org/article/69e6fdb4a43d4fcba4fec6488dc5fbc2
Autor:
Maria A. Malik, Nathan W. Sweeney, Mohammad Jafri, Andriy Derkach, Cynthia Chmielewski, Peter A. Adintori, Sham Mailankody, Neha Korde, Carlyn R. Tan, Hani Hassoun, Malin Hultcrantz, Jens Hillengass, Susan E. McCann, Neil Iyengar, Saad Usmani, Sergio A. Giralt, Ola Landgren, Marcel R. M. van den Brink, Jennifer M. Ahlstrom, Alexander M. Lesokhin, Anita D’Souza, Susan Chimonas, Urvi A. Shah
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-5 (2022)
Externí odkaz:
https://doaj.org/article/68536ec941d147189e0677f18c00e7f0